Ayrton Drug Manufacturing Ltd. Announces Unaudited Earnings Results for the First Quarter Ended Sep. 30, 2017
Ayrton Drug Manufacturing Ltd. announced unaudited earnings results for the first quarter ended Sep. 30, 2017. For the quarter, the company reported revenue of GHS 9,003,091 against GHS 9,132,709 a year ago. Operating Profit was GHS 1,646,745 against GHS 1,337,559 a year ago. Profit before taxation was GHS 1,223,603 against GHS 995,483 a year ago. Profit after tax was GHS 936,208 against GHS 696,454 a year ago. Earnings per share were GHS 0.0044 against GHS 0.0032 a year ago. Net cash flow from operating activities was GHS 485,124 against GHS 547,532.97 a year ago. Cash used in purchase of property, plant and equipment was GHS 30,769 against GHS 220,260 a year ago.